Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor based approach

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation: Differences According to Dose

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIM: To assess the risk of stroke and thromboembolism in patients with atrial fibrillation based on risk factor combinations of the CHA 2 DS 2 -VASc score.

METHODS AND RESULTS: Using nationwide Danish registries, patients with atrial fibrillation were included from 1997-2015 in this retrospective observational study. A multiple logistic regression, including interactions of history of stroke with age at AF, calendar year of AF, and the CHA 2 DS 2 VASc score risk factors (congestive heart failure, hypertension, diabetes, vascular disease, female sex), was used to predict the personalized risks of stroke within 1-year. A total of 147,842 patients with atrial fibrillation were included in the study cohort (median age 76 years, range 20 to 100 years, 51% females). Within the first year, 6% of the cohort were diagnosed with stroke. The predicted personalized 1-year absolute risk of stroke varied widely within each CHA 2 DS 2 -VASc score. To estimate the personalized risk of stroke an online calculator was created, the Calculator of Absolute Stroke Risk (CARS), which allows calculation of all the possible combinations of the CHA 2 DS 2 -VASc score. https://hjerteforeningen.shinyapps.io/riskvisrr/.

Calculation of the individual risk using a risk factor based approach as opposed to using average risk for a particular CHA 2 DS 2 -VASc score can improve risk estimates. Furthermore, CARS can assist in the communication of the stroke risk for a more evidence-based shared decision making of whether to initiate oral anticoagulation therapy.

Original languageEnglish
JournalEuropean heart journal. Cardiovascular pharmacotherapy
ISSN2055-6837
DOIs
Publication statusE-pub ahead of print - 12 Jun 2020

ID: 60061377